Caribou Biosciences, Inc.
CRBU · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 7, 2026 | — | 2.28M | — | -0.33 | — |
| 2026 Q1 | May 7, 2026 | 2.40M | 2.21M | -0.26 | -0.33 | — |
| 2025 Q4 | March 5, 2026 | 3.94M | 2.21M | -0.28 | -0.33 | +3.05% |
| 2025 Q3 | November 12, 2025 | 2.20M | 1.96M | -0.30 | -0.36 | -12.17% |
| 2025 Q2 | August 12, 2025 | 2.67M | 1.53M | -0.35 | -0.40 | +8.94% |
| 2025 Q1 | May 8, 2025 | 2.35M | 1.85M | -0.43 | -0.43 | +0.76% |
| 2024 Q4 | March 10, 2025 | 2.08M | 2.11M | -0.39 | -0.40 | -3.17% |
| 2024 Q3 | November 6, 2024 | 2.02M | 3.08M | -0.38 | -0.44 | +7.42% |
| 2024 Q2 | August 6, 2024 | 3.46M | 3.05M | -0.42 | -0.45 | — |
| 2024 Q1 | May 7, 2024 | 2.43M | 2.42M | -0.46 | -0.39 | — |
| 2023 Q4 | March 11, 2024 | 3.56M | 3.95M | -0.39 | -0.22 | +0.19% |
| 2023 Q3 | November 7, 2023 | 23.66M | 3.29M | -0.12 | -0.38 | — |
| 2023 Q2 | August 8, 2023 | 3.76M | 3.08M | -0.48 | -0.49 | -0.61% |
| 2022 Q4 | March 9, 2023 | 3.69M | 3.07M | -0.44 | -0.47 | — |
| 2022 Q3 | November 8, 2022 | 3.30M | 3.70M | -0.44 | -0.48 | +0.75% |